Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$155.97 - $200.09 $263,589 - $338,152
-1,690 Reduced 42.95%
2,245 $386,000
Q4 2020

Feb 10, 2021

SELL
$157.07 - $174.35 $538,278 - $597,497
-3,427 Reduced 46.55%
3,935 $651,000
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $318,483 - $384,154
2,323 Added 46.1%
7,362 $1.22 Million
Q2 2020

Aug 12, 2020

BUY
$111.92 - $142.53 $563,964 - $718,208
5,039 New
5,039 $691,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Red Cedar Investment Management, LLC Portfolio

Follow Red Cedar Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Cedar Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Cedar Investment Management, LLC with notifications on news.